Related Experiment Video
Updated: May 15, 2026
08:09
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
Genetics of scleroderma: implications for personalized medicine?
Shervin Assassi1, Timothy R D J Radstake, Maureen D Mayes
1Division of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX 77030, USA. shervin.assassi@uth.tmc.edu
BMC Medicine
|January 15, 2013
Summary
Recent genetic discoveries in systemic sclerosis (scleroderma) offer potential for personalized monitoring and treatment. Future research aims to develop genetic biomarkers for targeted therapies and improved patient outcomes.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Systemic sclerosis (scleroderma) is a complex autoimmune disease with a significant genetic component.
- Recent years have seen substantial progress in identifying genetic factors associated with systemic sclerosis.
- Understanding these genetic underpinnings is crucial for advancing patient care.
Purpose of the Study:
- To explore the potential of recent genetic discoveries in systemic sclerosis for personalized patient monitoring and treatment strategies.
- To investigate how genetic findings can inform the development of predictive biomarkers for treatment response.
- To highlight the future directions for genetic research in systemic sclerosis for targeted interventions.
Main Methods:
- Review of recent genetic studies identifying susceptibility loci and genes linked to disease manifestations in systemic sclerosis.
- Analysis of the potential for integrating genetic data into drug trial design and analysis.
- Discussion of future research needs, including well-characterized cohorts and advanced analytical approaches.
Main Results:
- Several robustly replicated genetic susceptibility loci for systemic sclerosis have been identified.
- Specific genes have been newly associated with diverse systemic sclerosis disease manifestations.
- Genetic studies hold promise for developing biomarkers to predict treatment efficacy.
Conclusions:
- Advances in understanding the genetics of systemic sclerosis pave the way for individualized patient management.
- Genetic biomarkers derived from future studies can enable targeted diagnostic and therapeutic interventions.
- Integrating genetic insights into clinical practice and research is key to improving outcomes for systemic sclerosis patients.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.